The ERG-Regulated


Journal

Molecular cancer research : MCR
ISSN: 1557-3125
Titre abrégé: Mol Cancer Res
Pays: United States
ID NLM: 101150042

Informations de publication

Date de publication:
10 2020
Historique:
received: 08 01 2020
revised: 04 06 2020
accepted: 29 06 2020
pubmed: 11 7 2020
medline: 1 9 2021
entrez: 11 7 2020
Statut: ppublish

Résumé

Numerous noncoding transcripts have been reported to correlate with cancer development and progression. Nevertheless, there remains a paucity of long noncoding RNAs (lncRNA) with well-elucidated functional roles. Here, we leverage the International Cancer Genome Consortium-Early Onset Prostate Cancer transcriptome and identify the previously uncharacterized lncRNA

Identifiants

pubmed: 32646965
pii: 1541-7786.MCR-20-0021
doi: 10.1158/1541-7786.MCR-20-0021
doi:

Substances chimiques

14-3-3 Proteins 0
ERG protein, human 0
FOXO1 protein, human 0
Forkhead Box Protein O1 0
Transcriptional Regulator ERG 0
YWHAE protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1545-1559

Informations de copyright

©2020 American Association for Cancer Research.

Auteurs

Arlou Kristina Angeles (AK)

Division of Cancer Genome Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.

Doreen Heckmann (D)

Division of Cancer Genome Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), and National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Niclas Flosdorf (N)

Division of Cancer Genome Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), and National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Stefan Duensing (S)

Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg, Germany.

Holger Sültmann (H)

Division of Cancer Genome Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), and National Center for Tumor Diseases (NCT), Heidelberg, Germany. h.sueltmann@dkfz.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH